My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Minerva Neurosciences, Inc - Common Stock (NQ:NERV)

4.120 +0.080 (+1.98%)

Streaming Delayed Price Updated: 2:20 PM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Minerva Neurosciences, Inc - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023

May 08, 2023

Management to Host Conference Call

From Minerva Neurosciences, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 01, 2023

Via Benzinga

Minerva Neurosciences Inc. (NASDAQ: NERV) Leading the Way in Monday Trading Based on Percentage Gain

May 01, 2023

Via Investor Brand Network

Minerva Neurosciences Announces the NDA Filing for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia

May 01, 2023

FDA grants appeal and files NDA

From Minerva Neurosciences, Inc

Via GlobeNewswire

Earnings Preview For Minerva Neurosciences ↗

March 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 26, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 11, 2023

Via Benzinga

Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business Updates

March 08, 2023

Company to Host Conference Call Today at 8:30 a.m. ET

From Minerva Neurosciences, Inc

Via GlobeNewswire

Minerva Neurosciences to Report Fiscal Year 2022 Financial Results and Business Updates on March 8, 2023

March 01, 2023

Management to Host Conference Call

From Minerva Neurosciences, Inc

Via GlobeNewswire

Earnings Scheduled For March 8, 2023 ↗

March 08, 2023

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 11, 2023

Via Benzinga

EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch ↗

December 29, 2022

Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information....

Via Benzinga

Tesla, Amazon, Minerva, Kala Pharma, Gorilla Tech: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

December 28, 2022

Major Wall Street indices closed in the red on Wednesday as investors and traders lost optimism regarding any possible year-end rebound and braced themselves for the new year while lightening up on...

Via Benzinga

Nasdaq Down 100 Points; Kala Pharmaceuticals Shares Spike Higher ↗

December 28, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 28, 2022

Via Benzinga

Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗

December 28, 2022

Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal...

Via Benzinga

Dow Tumbles 150 Points; Crude Oil Falls Sharply ↗

December 28, 2022

U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Wednesday.

Via Benzinga

US Stocks Rise; Dow Gains 100 Points ↗

December 28, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday.

Via Benzinga

Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia

December 28, 2022

From Minerva Neurosciences, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 06, 2022

Gainers

Via Benzinga

Greater Prevalence of Anxiety & Depressive Disorders Driving Demand for New Anti-Anxiety Drug Candidates

November 14, 2022

EQNX::TICKER_START (NASDAQ:SAGE),NASDAQ:NERV),(NASDAQ:ATAI),(NYSE:CYBN),(TSXV:MRVL),(NEO:CYBN), EQNX::TICKER_END

Via FinancialNewsMedia

Topics Retirement

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 ↗

November 10, 2022

Upgrades

Via Benzinga

Minerva Neurosciences Reports Third Quarter 2022 Financial Results and Business Updates

November 09, 2022

Company To Host Live Webcast Today at 8:30 a.m. ET

From Minerva Neurosciences, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 09, 2022

Gainers Merrimack Pharmaceuticals (NASDAQ:MACK) shares rose 180.0% to $11.2 during Wednesday's pre-market session. The company's market cap stands at $150.1 million. As per the news, the Q3 earnings...

Via Benzinga

Minerva Neurosciences to Report Third Quarter 2022 Financial Results and Business Updates on November 9, 2022

November 02, 2022

From Minerva Neurosciences, Inc

Via GlobeNewswire

Why IBM Shares Are Trading Higher; Here Are 21 Stocks Moving Premarket ↗

October 20, 2022

Gainers COMSovereign Holding Corp. (NASDAQ: COMS) rose 20.9% to $0.1063 in pre-market trading after dipping 26% on Wednesday. COMSovereign recently announced receipt of Nasdaq listing determination.

Via Benzinga

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday ↗

October 18, 2022

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

Via Benzinga

Dow Rises Over 2%; S&P 500 Up 100 Points ↗

October 17, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 300 points on Monday.

Via Benzinga

Virgin Orbit And 4 More Short Squeeze Stocks That Could Soar This Week — Including A Stock Moving Up 968 Positions ↗

October 17, 2022

Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 17, 2022

Gainers

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.